2008
DOI: 10.3748/wjg.14.2065
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Prometheus liver assist system on systemic hemodynamics in patients with cirrhosis: A randomized controlled study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
28
1
10

Year Published

2010
2010
2019
2019

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 51 publications
(39 citation statements)
references
References 23 publications
(32 reference statements)
0
28
1
10
Order By: Relevance
“…One of the main reasons for the scarcity of data seems to be the limited number of studied patients. Another notable fact is that there are no standards applicable to the use of these techniques [7,[11][12][13][14][15][16][17][18][19][20][21].…”
Section: Introductionmentioning
confidence: 99%
“…One of the main reasons for the scarcity of data seems to be the limited number of studied patients. Another notable fact is that there are no standards applicable to the use of these techniques [7,[11][12][13][14][15][16][17][18][19][20][21].…”
Section: Introductionmentioning
confidence: 99%
“…Se seleccionaron 8 ensayos clínicos aleatorizados [12][13][14][15][16][17][18][19] y un metaanálisis 20 que abordaban la eficacia y la seguridad del sistema MARS s , además de 2 estudios de coste-efectividad sobre la técnica 21,22 . Once estudios evaluaron el sistema Prometheus s : 6 eran series de casos 23-28 y el resto, ensayos clínicos aleatorizados 15,17,[29][30][31] .…”
Section: Resultados Estudios Clínicos Incluidosunclassified
“…Once estudios evaluaron el sistema Prometheus s : 6 eran series de casos 23-28 y el resto, ensayos clínicos aleatorizados 15,17,[29][30][31] . No se localizaron estudios que evaluasen la técnica de soporte hepático Prometheus s desde un punto de vista económico.…”
Section: Resultados Estudios Clínicos Incluidosunclassified
See 1 more Smart Citation
“…amino acids [12], and ammonia [9], with conflicting results relating inflammation markers such as tumor necrosis factor-alpha [10,13,14], and interleukin-6 [10,14]. MARS was described in the improvement of hemodynamic parameters such as mean arterial pressure in 2 randomized, controlled studies, although no clinical outcome could be associated [7,15].…”
Section: Discussionmentioning
confidence: 99%